Noelia
Casares Lagar
Investigadora Asociada
![Foto de Noelia](/img/nophoto.png)
![Foto de Instituto de Investigación Sanitaria de Navarra](/img/noimage_org.png)
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Navarra (20)
2023
-
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
Frontiers in Immunology, Vol. 13
-
Erratum: Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies(Front. Immunol., (2023), 13, (1044025), 10.3389/fimmu.2022.1044025)
Frontiers in Immunology
-
FOXP3 expression diversifies the metabolic capacity and enhances the efficacy of CD8 T cells in adoptive immunotherapy of melanoma
Molecular Therapy, Vol. 31, Núm. 1, pp. 48-65
-
Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies
EMBO Molecular Medicine, Vol. 15, Núm. 11
-
Silver nanoparticles induce a non-immunogenic tumor cell death
Journal of Immunotoxicology, Vol. 20, Núm. 1
-
Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer
Viruses, Vol. 15, Núm. 9
2022
-
Impact of tumor microenvironment on adoptive T cell transfer activity
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 1-31
-
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 8
2021
-
Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model
Journal of Nanobiotechnology, Vol. 19, Núm. 1
-
Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 11
-
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses
Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946
2020
-
Cellular cytotoxicity is a form of immunogenic cell death
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1
-
Long-term systemic expression of a novel pd-1 blocking nanobody from an aav vector provides antitumor activity without toxicity
Biomedicines, Vol. 8, Núm. 12, pp. 1-19
2019
-
A new immune-nanoplatform for promoting adaptive antitumor immune response
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 13-25
-
Today's special on the anticancer menu: Immunomodulation by antifolates
Clinical Cancer Research, Vol. 25, Núm. 23, pp. 6890-6892
-
Treatment of experimental autoimmune encephalomyelitis by sustained delivery of low-dose IFN-a
Journal of Immunology, Vol. 203, Núm. 3, pp. 696-704
2018
-
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer
OncoImmunology, Vol. 7, Núm. 4
2017
-
Expansion of tumor-infiltrating CD8+ T cells expressing PD-1 improves the efficacy of adoptive T-cell therapy
Cancer Research, Vol. 77, Núm. 13, pp. 3672-3684
2015
-
A core of kinase-regulated interactomes defines the neoplastic MDSC lineage
Oncotarget, Vol. 6, Núm. 29, pp. 27160-27175
-
Inhibition of FOXP3/NFAT interaction enhances T cell function after TCR stimulation
Journal of Immunology, Vol. 195, Núm. 7, pp. 3180-3189